Business Context and Reporting Period
Company: Universal Health Services, Inc. (UHS)
Filing Type: Form 10-K (Annual Report)
Period Ended: December 31, 2001
Business Overview: UHS owns and operates acute care hospitals, behavioral health centers, ambulatory surgery centers, and radiation oncology centers. As of year-end 2001, the Company operated 73 facilities (35 acute care, 38 behavioral health) across 22 U.S. states, Washington D.C., Puerto Rico, and France. The Company also manages 23 ambulatory surgery and radiation oncology centers.
Key Financial Metrics
| Metric (in thousands) | 2001 | 2000 | 1999 |
|---|---|---|---|
| Net Revenues | $2,840,491 | $2,242,444 | $2,042,380 |
| Net Income | $99,742 | $93,362 | $77,775 |
| Net Margin | 3.5% | 4.2% | 3.8% |
| Operating Income | $441,921 | $359,325 | $318,568 |
| Operating Margin | 15.6% | 16.0% | 15.6% |
| Cash from Operating Activities | $312,187 | $182,454 | $175,557 |
| Capital Expenditures | $160,748 | $115,751 | $68,695 |
| Total Assets | $2,114,584 | $1,742,377 | $1,497,973 |
| Long-Term Debt | $718,830 | $548,064 | $419,203 |
| Debt to Total Capitalization | 47% | 43% | 40% |
| Earnings Per Share (Diluted) | $1.60 | $1.50 | $1.22 |
Material Changes vs. Prior Period
- Revenue Growth: Net revenues increased 27% to $2.84 billion in 2001 compared to 2000. This was driven by a 13% increase in revenues from existing facilities and $324 million in revenues from 28 new facilities acquired in the U.S. and France since late 2000.
- Profitability: Net income rose 7% to $99.7 million. However, net margin declined to 3.5% from 4.2% in 2000 due to significant non-recurring charges and rising operating costs.
- Operating Margins: Overall operating margins remained relatively flat at 15.6%, though acute care margins declined slightly to 17.8% due to increased labor, pharmaceutical, and insurance costs. Behavioral health margins improved to 19.0%.
- Acquisitions: The Company spent $263 million in 2001 to acquire assets including four acute care facilities, three behavioral health centers, an 80% interest in a French hospital operator (9 hospitals), and two ambulatory surgery centers.
- Debt Levels: Long-term debt increased by approximately $171 million to $719 million, reflecting financing for acquisitions and capital projects. The debt-to-capitalization ratio rose to 47%.
Guidance, Outlook, Risks, and Unusual Items
Unusual Items and Charges
- Insurance Reserve Charge: A $40 million pre-tax charge was recorded in Q4 2001 to reserve for malpractice expenses following the liquidation of the Company's third-party insurer, PHICO. The Company expects to self-insure up to $25 million per occurrence starting in 2002.
- Derivative Losses: A $7.4 million pre-tax loss was recorded due to the early termination of interest rate swaps.
- Debt Extinguishment: A $1.6 million pre-tax extraordinary charge resulted from the early redemption of $135 million in Senior Notes.
Outlook and Management Commentary
- Cost Pressures: Management anticipates continued pressure on operating margins due to rising labor rates (particularly for skilled nursing), pharmaceutical costs, and insurance expenses. Total insurance expense is expected to increase by approximately $25 million in 2002.
- Capital Expenditures: Projected capital expenditures for 2002 range from $215 million to $265 million, including a new hospital in Washington, D.C., and expansions in Las Vegas.
- Regulatory Environment: The Company faces ongoing risks related to Medicare/Medicaid reimbursement rates (PPS and OPPS systems) and the implementation of HIPAA regulations, though management does not expect HIPAA implementation costs to be material.
- State Programs: The Company relies on special Medicaid reimbursement programs in Texas and South Carolina ($32.6 million in 2001). These programs are scheduled to terminate in Q3 2002; failure to renew them could materially adversely affect future results.
Investor Verification Checklist
- PHICO Liability: Verify the adequacy of the $40 million reserve for malpractice claims and the potential for additional liability if the ultimate cost exceeds estimates.
- Insurance Costs: Monitor the impact of the shift to self-insurance and rising commercial insurance rates on 2002 operating margins.
- State Reimbursement Renewal: Confirm the status of the Texas and South Carolina disproportionate share hospital fund programs, which are critical to revenue stability.
- Acquisition Integration: Assess the financial performance of the 28 facilities acquired since late 2000, particularly the French hospital operations.
- Debt Covenants: Review compliance with debt covenants regarding minimum net worth and fixed charge coverage ratios, given the increased leverage.